*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also manufactures innovative scientific instruments including the culex® automated in vivo sampling system which can collect blood, bile, microdialysates, activity behavior, telemetry data and more from awake, freely-moving subjects. we are known for our scientific expertise, responsiveness to clients, exemplary regulatory record, and helping our clients meet key milestones on time.
Company profile
Ticker
NOTV
Exchange
Website
CEO
Robert Leasure
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • OmniAb ...
Former names
BIOANALYTICAL SYSTEMS INC
SEC CIK
Corporate docs
Subsidiaries
BAS Evansville, Inc. • BASi Gaithersburg, LLC • Bronco Research • Envigo Bioproducts, Inc. • Envigo Global Services, Inc. • Envigo Holding I, Inc. • Envigo RMS B.V., Inc. • Envigo RMS, LLC • ERPP, Inc. • Histion, LLC ...
IRS number
351345024
NOTV stock data
Latest filings (excl ownership)
8-K
Inotiv, Inc. Announces Changes to its Board Composition
19 Oct 23
10-Q
2023 Q3
Quarterly report
11 Aug 23
8-K
Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update
10 Aug 23
10-Q
2023 Q2
Quarterly report
15 May 23
8-K
Inotiv, Inc. Announces Second Quarter Fiscal 2023 Financial Results
11 May 23
8-K
Submission of Matters to a Vote of Security Holders
17 Mar 23
10-Q
2023 Q1
Quarterly report
14 Feb 23
8-K
Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results
13 Feb 23
DEFA14A
Additional proxy soliciting materials
27 Jan 23
DEF 14A
Definitive proxy
27 Jan 23
Transcripts
NOTV
Earnings call transcript
2023 Q3
10 Aug 23
NOTV
Earnings call transcript
2023 Q2
11 May 23
NOTV
Earnings call transcript
2023 Q1
13 Feb 23
NOTV
Earnings call transcript
2022 Q4
10 Jan 23
NOTV
Earnings call transcript
2022 Q3
11 Aug 22
NOTV
Earnings call transcript
2022 Q2
13 May 22
NOTV
Earnings call transcript
2022 Q1
11 Feb 22
NOTV
Earnings call transcript
2021 Q4
17 Dec 21
NOTV
Earnings call transcript
2021 Q3
12 Aug 21
NOTV
Earnings call transcript
2021 Q2
8 May 21
Latest ownership filings
Financial summary
| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 22 | Sep 21 | Sep 20 | Sep 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q2 2023
5.3% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 25.58 mm |
| Total shares | 1.38 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Jermyn Street Associates | 1.38 mm | $25.58 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Oct 23 | Mary Theresa Coelho | Common Stock | Grant | Acquire A | No | No | 0 | 12,911 | 0.00 | 12,911 |
| 1 Apr 23 | Nigel Brown | Common Stock | Grant | Acquire A | No | No | 0 | 25,822 | 0.00 | 30,537 |
| 1 Apr 23 | David Landman | Common Stock | Grant | Acquire A | No | No | 0 | 25,822 | 0.00 | 25,822 |
News
Inotiv's Earnings Outlook
8 Dec 23
Inotiv Plans Taking Direct Control Of Its Transportation Operations; Will Be Partnering With Vanguard Supply Chain Solutions To Enable The In-house Integration
6 Dec 23
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
16 Oct 23
Stocks That Hit 52-Week Lows On Thursday
21 Sep 23
Press releases
Inotiv, Inc. Announces Plan to Insource North American Transportation Operations
6 Dec 23
Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023
27 Nov 23
Inotiv Ranked Number 127 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
8 Nov 23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV
9 Oct 23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV
29 Sep 23